Total trials
335
Active
40
Phase 3
20
Total enrollment
103,100
Pipeline matrix
Showing 12 of 12 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| L-methylfolate | — | — | — | — | — | 1 | |
| Vaginal Estrogen - Twice Weekly | — | — | — | — | — | 1 | |
| Vaginal Estrogen - Daily | — | — | — | — | — | 1 | |
| Gemcitabine + BCG | — | — | — | — | — | 1 | |
| BCG | — | — | — | — | — | 1 | |
| Psilocybin | — | — | — | — | — | 1 | |
| Caffeine | — | — | — | — | — | 1 | |
| Ketamine | — | — | — | — | 3 | ||
| Genetic testing for inherited bleeding disorders | — | — | — | — | — | 1 | |
| Allergenic Extract Standardized Cat Hair Acetone-Precipitated | — | — | — | — | — | 1 | |
| Vaccination Provision | — | — | — | — | — | 1 | |
| Vaccination Provision 2 | — | — | — | — | — | 1 |
Next readouts
- 2026-01
- 2026-01-08
- 2026-04-01
- 2026-06-01
- 2026-12-31
- 2027-07-31
- 2027-09-30
- 2028-03-31
- 2029-09
Top conditions
- Depression13
- Obesity8
- Healthy7
- Chronic Obstructive Pulmonary Disease7
- Physical Activity7
- Dementia6
- Hypertension6
- Glaucoma6
Frequently asked questions about Queen's University
- How many clinical trials does Queen's University have on ClinicalTrials.gov?
- Queen's University is listed as the lead sponsor on 335 clinical trials in ClinicalTrials.gov, 40 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Queen's University's trials are in Phase 3?
- 20 of Queen's University's trials are in Phase 3, spread across 12 active drug programs.
- What therapeutic areas does Queen's University focus on?
- Queen's University's most-studied conditions on ClinicalTrials.gov are Depression, Obesity, Healthy, Chronic Obstructive Pulmonary Disease, Physical Activity.
- When are Queen's University's next clinical trial readouts?
- Queen's University has 9 upcoming primary-completion readouts tracked here; the soonest is “Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living with HIV”, expected around 2026-01.